Enhanced Perinatal Surveillance—Participating Areas in the United States and Dependent Areas, 2000–2003
HIV/AIDS Surveillance Supplemental Report, Volume 13, Number 4
On this Page
Contents
| Figure and Tables | |
|---|---|
| Figure 1 | Location of enhanced perinatal surveillance areas, 2000–2003 |
| Table 1 | Number and percentage of HIV-infected pregnant women who gave birth to a live infant, by year of infant’s birth and selected characteristics of mother, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 2 | Prenatal care of HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 3 | Timing of HIV testing of HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 4 | Receipt of antiretroviral therapy by HIV-infected women and HIV-exposed infants, by timing of receipt and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 5 | Method of delivery for HIV-infected women, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 6 | Substance use and toxicology screening of HIV-infected women during pregnancy, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 7 | Screening of HIV-infected women during pregnancy, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 8 | Number and percentage of HIV-infected women with positive test results for selected conditions, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 9 | Prenatal care of HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 10 | Timing of HIV testing of HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 11 | Receipt of antiretroviral therapy by HIV-infected women and HIV exposed infants, by timing of receipt, race/ethnicity, and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 12 | Method of delivery for HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 13 | Substance use and toxicology screening of HIV-infected women during pregnancy, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 14 | Type of birth, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 15 | Number and percentage of infants receiving prophylaxis against Pneumocystis jiroveci pneumonia, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 16 | Number and percentage of infants infected with HIV through mother-to-child transmission, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 17 | Birth weight (grams) of children born to HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 18 | Gestational age at birth among HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 19 | Birth defects in first year of life in children born to HIV-infected women, by race/ethnicity and year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 20 | Number and percentage of HIV-infected women who gave birth to a live infant and received medical treatment reimbursement, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |
| Table 21 | Type of facility where prenatal care was provided, by year of infant’s birth, 2000–2003—24 areas conducting enhanced perinatal surveillance in the United States and dependent areas |




